Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2026)

Vir Biotechnology has disclosed Goodwill & Intangibles across 9 years of filings, most recently posting $24.7 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $24.7 million, down 1.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.7 million (down 1.18% YoY), and the FY2025 annual result was $24.8 million, down 1.08% from the prior year.
• Goodwill & Intangibles came in at $24.7 million for Q1 2026 at Vir Biotechnology, roughly flat from $24.8 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $50.1 million in Q1 2022 to a low of $24.7 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $39.4 million (2024), against an average of $37.3 million.
• Across the five-year window, Goodwill & Intangibles slipped 1.05% in 2022 and plunged 36.57% in 2024, its largest moves.
• Vir Biotechnology's Goodwill & Intangibles stood at $49.7 million in 2022, then fell by 20.51% to $39.5 million in 2023, then sank by 36.57% to $25.1 million in 2024, then slipped by 1.08% to $24.8 million in 2025, then slipped by 0.29% to $24.7 million in 2026.
• The last three Goodwill & Intangibles figures came in at $24.7 million (Q1 2026), $24.8 million (Q4 2025), and $24.9 million (Q3 2025), per Business Quant data.